TPD & Induced Proximity Summit Leaderboard
  • Friday, July 31, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 795

Author

Pharma Journalist 8969 posts 0 comments

Roche and Ignyta Reach Definitive Merger Agreement

Jan 2, 2018
Roche and Ignyta announced they have entered into a definitive merger agreement for Roche to fully acquire Ignyta at a price of US$ 27.00 per share in an all-cash transaction. This…
Read More...

Nanobiotix’s first immuno-oncology trial approved by U.S. FDA

Jan 2, 2018
Nanobiotix SA Announces that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) Application for NBTXR3, a first-in-class nanoparticle designed…
Read More...

Confo Therapeutics enters into Drug Discovery Collaboration with Roche

Dec 19, 2017
Confo Therapeutics announced that it has entered into a research collaboration and license agreement with Roche for the discovery, development and commercialisation of novel, small…
Read More...

DiCE Molecules announce Multi-Year Research Collaboration with Genentech

Dec 19, 2017
DiCE Molecules announced a multi-year collaboration to discover new small molecules against multiple targets of interest to Genentech. The collaboration will build upon DiCE’s unique…
Read More...

Avista Pharma Solutions expands Drug Product cGMP Manufacturing at Colorado Site

Dec 19, 2017
Avista Pharma Solutions has completed extensive facility upgrades at its Longmont, Colorado site, expanding its drug product manufacturing footprint by approximately 20,000 square feet…
Read More...

BioLife Solutions executes supply agreement with Iovance Biotherapeutics

Dec 19, 2017
BioLife Solutions announced that it has executed an agreement to supply its CryoStor cell freeze media and HypoThermosol cell storage and shipping media to Iovance Biotherapeutics.…
Read More...

Aratana Therapeutics announces study results for AT-016

Dec 19, 2017
Aratana Therapeutics, Inc. has received top-line pivotal field effectiveness study results for AT-016, an investigational adipose-derived allogeneic stem cell therapeutic candidate for…
Read More...

Teva Announces Exclusive Launch of Generic Viread in the United States

Dec 19, 2017
Teva Pharmaceutical Industries Ltd., announced the exclusive launch of generic Viread®1 (tenofovir disoproxil fumarate) tablets 300 mg in the U.S. Tenofovir disoproxil fumarate…
Read More...

Celltrion Receives Positive CHMP Opinion for Herzuma for Trastuzumab Biosimilar

Dec 19, 2017
Celltrion, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma®…
Read More...

PixarBio Corporation announces signed agreement with Lubrizol’s Division

Dec 19, 2017
PixarBio Corporation developers of NeuroRelease NR14, a 14-day post-surgical pain treatment, announces an agreement between Particle Sciences (PSI), a Lubrizol Corporation Company, to…
Read More...
Prev Next
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • From Innovation to Acquisition: CrossBridge Bio’s ADC Journey
  • COPD Foundations Joins the COPD Drug Development Summit
  • argenx to Acquire Forte Biosciences in $2.2 Billion Deal
  • BioMarin, n-Lorem Join Forces on ReNU Syndrome Therapy
  • Pfizer, Eisai Partner to Co-Promote Nurtec in Japan

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.